New Genes for Breast Cancer In Women of Africa Rising can improve the prediction of the disease

A study of 12 genes of breast cancer in women of Africa’s emergence can one day help better predict the risk of the disease, and emphasize the differences in the potential risk of women of European origin. The researchers wrote on Monday in the journal “Nature Gentex”, where the results of the study published on Monday, that some of the mutations identified were not previously linked to the disease or that it was not strongly linked, as in this new analysis, which indicates that genetic risk factors may differ between women and European descent. The researchers said that one of the mutations they recently identified is particularly linked to the disease that is strongly “rarely observed” in the field of genetics related to cancer, while indicating that some other genes known to increase the risk of breast cancer in white women are not related to the disease in this study. The study withdrew the new results of more than 40,000 Africa women in the United States, Africa and Burpados, including 18 thousand and 34 with breast cancer. Negative threefold breast cancer and 6 genetic mutations are associated with the high risk of infection with a negative triple breast cancer “, which is the fiercest form of the disease. Previous research has shown that women from Africa origin are at increased risk of this kind of breast cancer of about 3 times the same in white women. The study also found that women who carry the six genes are all 4.2 times more likely to diagnose negative triple breast cancer compared to the fact that they do not have any of these genes, or only one of them. “The benefit of the new variables requires more evaluation before the test is available regularly.” Studies, conducted to identify genetic mutations associated with breast cancer, focused mainly on European women, but the American Cancer Society has indicated that Africa women in the United States are suffering from higher breast cancer figures before the age of 50, the high infection in the infection is difficult to treat, and the death rate of the disease is 42 % of white women. The association pointed out that many genetic mutations identified in the past as a risk of breast cancer in white women are also strongly linked to the risks of illness in women in Africa, and it is recommended to perform genetic tests for all patients, regardless of race.